×

CETUXIMAB WITH MODIFIED GLYCOSYLATION AND USES THEREOF

  • US 20160002330A1
  • Filed: 02/13/2014
  • Published: 01/07/2016
  • Est. Priority Date: 02/13/2013
  • Status: Abandoned Application
First Claim
Patent Images

1. A glycosylated antibody comprising:

  • (a) a heavy chain comprising SEQ ID NO;

    1;

    (b) a light chain comprising SEQ ID NO;

    2;

    wherein the glycosylated antibody has fewer galactose-alpha-1,3-galactose moieties than the glycosylated antibody produced in non-mammary cell culture.

View all claims
  • 3 Assignments
Timeline View
Assignment View
    ×
    ×